Quantinno Capital Management LP Eli Lilly & CO Transaction History

Quantinno Capital Management LP

$7.54 Billion
Q3 2024

A detailed history of Quantinno Capital Management LP transactions in Eli Lilly & CO stock. As of the latest transaction made, Quantinno Capital Management LP holds 61,268 shares of LLY stock, worth $48.7 Million. This represents 0.72% of its overall portfolio holdings.

Number of Shares

61,268

Previous 48,066 27.47%

Holding current value

$48.7 Million

Previous $43.5 Million 24.73%

% of portfolio

0.72%

Previous 0.8%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$772.14 - $960.02 $10.2 Million - $12.7 Million	13,202 Added 27.47%	61,268 $54.3 Million
Q2 2024 Aug 14, 2024	BUY	$724.87 - $909.04 $1.16 Million - $1.46 Million	1,607 Added 3.46%	48,066 $43.5 Million
Q1 2024 May 14, 2024	BUY	$592.2 - $792.28 $8.66 Million - $11.6 Million	14,631 Added 45.97%	46,459 $36.1 Million
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $1.93 Million - $2.27 Million	3,670 Added 13.03%	31,828 $18.6 Million
Q3 2023 Nov 14, 2023	BUY	$434.7 - $599.3 $2.95 Million - $4.06 Million	6,777 Added 31.7%	28,158 $15.1 Million
Q2 2023 Aug 04, 2023	BUY	$350.74 - $468.98 $2.97 Million - $3.96 Million	8,454 Added 65.4%	21,381 $10 Million
Q1 2023 May 03, 2023	SELL	$310.63 - $364.82 $1.59 Million - $1.87 Million	-5,113 Reduced 28.34%	12,927 $4.44 Million
Q4 2022 Feb 13, 2023	BUY	$321.55 - $374.67 $2.96 Million - $3.45 Million	9,217 Added 104.47%	18,040 $6.6 Million
Q3 2022 Nov 07, 2022	BUY	$296.48 - $337.87 $215,244 - $245,293	726 Added 8.97%	8,823 $2.85 Million
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $1.59 Million - $1.86 Million	5,689 Added 236.25%	8,097 $2.63 Million
Q1 2022 May 12, 2022	SELL	$234.69 - $291.66 $1.5 Million - $1.86 Million	-6,374 Reduced 72.58%	2,408 $690,000
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $1.97 Million - $2.45 Million	8,782 New	8,782 $2.43 Million
Q3 2019 Nov 14, 2019	SELL	$106.79 - $116.16 $210,803 - $229,299	-1,974 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $99,157 - $115,741	-895 Reduced 31.2%	1,974 $219,000
Q1 2019 May 14, 2019	SELL	$111.31 - $131.02 $85,152 - $100,230	-765 Reduced 21.05%	2,869 $372,000
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $384,840 - $431,137	3,634 New	3,634 $421,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantinno Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantinno Capital Management LP with notifications on news.

Account

Quantinno Capital Management LP Eli Lilly & CO Transaction History